A Supplemental Report on British Columbia’s Unregulated Drug Supply Amidst Dual Public Health Emergencies: Results from British Columbia’s Community Drug Checking Service, January 2020 – October 2020. Long V, Tobias S, Lysyshyn M, Sage C, Bridgeman…

The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England.  Whitfield M, Reed H, Webster J, Hope V.  Int J Drug Policy. 2020 Sep;83:102851. doi: 10.1016/j.drugpo.2020.102851. Epub 2020 Jul 15…

Syringe services program (SSP) operational changes during the COVID-19 global outbreak.  Bartholomew TS, Nakamura N, Metsch LR, Tookes HE.  Int J Drug Policy. 2020 Sep;83:102821. doi: 10.1016/j.drugpo.2020.102821. Epub 2020 Jun 12. PMID…

Challenges of providing COVID-19 prevention services to homeless people who use drugs in Iran.  Deilamizade A, Moghanibashi-Mansourieh A. Int J Drug Policy. 2020 Sep;83:102806. doi: 10.1016/j.drugpo.2020.102806. Epub 2020 Jun 3. PMID: 32513622…

The impact of COVID-19 on harm reduction in seven Asian countries  Understanding the impact of COVID-19 on harm reduction funding and service provision is essential for informing donor and government action as well as civil society advocacy. T…

Webinar. What can we learn from the COVID-19 pandemic? COVID-19 and the impact on harm reduction in Europe Since the beginning of 2020, European countries have experienced an unprecedented public health threat with the emergence of COVID-19. In res…